Adalimumab rapidly controls both anterior and posterior inflammation in patients with ocular Behçet syndrome and non-infectious uveitis refractory to conventional therapy: a prospective, 6-month follow-up investigation-Reference-Cited by-同舟云学术

Adalimumab rapidly controls both anterior and posterior inflammation in patients with ocular Behçet syndrome and non-infectious uveitis refractory to conventional therapy: a prospective, 6-month follow-up investigation

Published:2023-08-09 Issue:12 Volume:43 Page:4461-4472
ISSN:1573-2630
Container-title:International Ophthalmology
language:en
Short-container-title:Int Ophthalmol

Author:

Evereklioglu Cem^ORCID,Sonmez Hatice Kubra^ORCID,Sevim Duygu Gulmez^ORCID,Arda Hatice^ORCID,Sener Hidayet^ORCID,Polat Osman Ahmet^ORCID,Horozoglu Fatih^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Ophthalmology

Link

https://link.springer.com/content/pdf/10.1007/s10792-023-02846-4.pdf

Reference19 articles.

1. Evereklioglu C (2005) Current concepts in the etiology and treatment of Behçet disease. Surv Ophthalmol 50:297–350

2. Evereklioglu C (2004) Managing the symptoms of Behçet’s disease. Expert Opin Pharmacother 5:317–328

3. Evereklioglu C, Er H, Türköz Y, Çekmen M (2002) Serum levels of TNF-α, sIL-2R, IL-6, and IL-8 are increased and associated with elevated lipid peroxidation in patients with Behçet’s disease. Mediat Inflamm 11:87–93

4. Evereklioglu C, Borlu M (2008) Sustained remission after infliximab in a child with systemic vasculitis refractory to conventional immunosuppressive therapy including interferon-α. Br J Ophthalmol 92:1034

5. Evereklioglu C (2011) Ocular Behçet disease: current therapeutic approaches. Curr Opin Ophthalmol 22:508–516

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multiple drugs;Reactions Weekly;2024-08-31

2. The Frequency of Intraocular Pressure Elevation, Incidence of Secondary Glaucoma, and Surgical Treatment With Postoperative Complications in Pediatric and Adult Patients With Uveitis;Cureus;2024-03-07

3. Options for systemic therapy of uveitis including alternative therapies;Expert Review of Ophthalmology;2024-03-05